Clinical Trial

A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a multi-center, phase Ib/II trial to evaluate the safety and efficacy of CNCT19 treatment in Children and Adolescent (pediatric) patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-cell ALL).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-12-19; most recent amendment 2025-08-11.
Status change: Not Yet Recruiting → Recruiting 2023-03-24
Trial Details
NCT Number NCT05667506
Lead Sponsor Juventas Cell Therapy Ltd.
Conditions B-cell Acute Lymphoblastic Leukemia
Enrollment 47 participants
Start Date 2023-02-07
Primary Completion 2025-05-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-12